These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9491965)

  • 1. Diagnostic performance of the EMIT-tox benzodiazepine immunoassay, FPIA serum benzodiazepine immunoassay, and radioreceptor assay in suspected acute poisoning.
    Verstraete AG; Belpaire FM; Leroux-Roels GG
    J Anal Toxicol; 1998; 22(1):27-32. PubMed ID: 9491965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Emit tox benzodiazepine and barbiturate assays on the Vitalab Viva analyser and FPIA on the Abbott ADx analyser.
    Charlier CJ; Plomteux GJ
    Clin Chem Lab Med; 2000 Jul; 38(7):615-8. PubMed ID: 11028766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Abbott ADx and TDx serum benzodiazepine immunoassays for analysis of alprazolam.
    Fraser AD; Bryan W
    J Anal Toxicol; 1991; 15(2):63-5. PubMed ID: 1675703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoassay detection of nordiazepam, triazolam, lorazepam, and alprazolam in blood.
    Huang W; Moody DE; Andrenyak DM; Rollins DE
    J Anal Toxicol; 1993 Oct; 17(6):365-9. PubMed ID: 7903726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of the benzodiazepine plasma concentrations in suicidal patients using a radioreceptor assay.
    de Jong LA; Verwey B; Essink G; Muntendam A; Zitman FG; Ensing K
    J Anal Toxicol; 2004 Oct; 28(7):587-92. PubMed ID: 15516318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary screening for benzodiazepines with radioreceptor assay: comparison with EMIT d.a.u. benzodiazepine assay and high-performance liquid chromatography.
    Borggaard B; Joergensen I
    J Anal Toxicol; 1994 Sep; 18(5):243-6. PubMed ID: 7990439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The online screening technique for urinary benzodiazepines: comparison with EMIT, FPIA, and GC-MS.
    Beck O; Lin Z; Brodin K; Borg S; Hjemdahl P
    J Anal Toxicol; 1997; 21(7):554-7. PubMed ID: 9399125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benzodiazepines: toxic serum concentrations in positive enzyme immunoassay responses.
    Divanon F; Debruyne D; Moulin M; Leroyer R
    J Anal Toxicol; 1998; 22(7):559-66. PubMed ID: 9847005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diazepam poisoning with one-month monitoring of diazepam and nordiazepam blood levels.
    de Haro L; Valli M; Bourdon JH; Iliadis A; Hayek-Lanthois M; Arditti J
    Vet Hum Toxicol; 2001 Jun; 43(3):174-5. PubMed ID: 11383664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New modified fluorescence polarization immunoassay does not falsely elevate vancomycin concentrations in patients with end-stage renal disease.
    Smith PF; Petros WP; Soucie MP; Copeland KR
    Ther Drug Monit; 1998 Apr; 20(2):231-5. PubMed ID: 9558140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the sensitivity and specificity of six immunoassays for the detection of amphetamines in urine.
    Verstraete AG; Heyden FV
    J Anal Toxicol; 2005; 29(5):359-64. PubMed ID: 16105261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxaprozin cross-reactivity in three commercial immunoassays for benzodiazepines in urine.
    Fraser AD; Howell P
    J Anal Toxicol; 1998; 22(1):50-4. PubMed ID: 9491969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the Abbott TDx serum benzodiazepine immunoassay for the analysis of lorazepam, adinazolam, and N-desmethyladinazolam.
    Fraser AD; Bryan W
    J Anal Toxicol; 1995 Sep; 19(5):281-4. PubMed ID: 7500613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary screening for adinazolam and its major metabolites by the Emit d.a.u. and FPIA benzodiazepine assays with confirmation by HPLC.
    Fraser AD; Isner AF; Bryan W
    J Anal Toxicol; 1993; 17(7):427-31. PubMed ID: 8309217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Falsely elevated serum vancomycin concentrations in hemodialysis patients.
    Follin SL; Mueller BA; Scott MK; Carfagna MA; Kraus MA
    Am J Kidney Dis; 1996 Jan; 27(1):67-74. PubMed ID: 8546140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of an enzyme immunoassay for determining diazepam and nordiazepam in serum and urine.
    Wallace JE; Harris SC; Shimek EL
    Clin Chem; 1980 Dec; 26(13):1905-7. PubMed ID: 6777085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limitations of EMIT benzodiazepine immunoassay for monitoring compliance of patients with benzodiazepine therapy even after hydrolyzing glucuronide metabolites in urine to increase cross-reactivity: comparison of immunoassay results with LC-MS/MS values.
    Dixon RB; Floyd D; Dasgupta A
    Ther Drug Monit; 2015 Feb; 37(1):137-9. PubMed ID: 25004136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absorption of diazepam after its rectal administration in dogs.
    Papich MG; Alcorn J
    Am J Vet Res; 1995 Dec; 56(12):1629-36. PubMed ID: 8599525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved screening for benzodiazepine metabolites in urine using the Triage Panel for Drugs of Abuse.
    Koch TR; Raglin RL; Kirk S; Bruni JF
    J Anal Toxicol; 1994; 18(3):168-72. PubMed ID: 7914948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a fluorescence polarization immunoassay for lorazepam quantification.
    Agbuya PG; Li L; Miles MV; Zaritsky AL; Morris AD
    Ther Drug Monit; 1996 Apr; 18(2):194-9. PubMed ID: 8721284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.